Cited by 17Health Systems, Economic Evaluations, Quality of LifeDiabetes Treatment and ManagementDiabetes Management and Education

Improving quality of care in people with Type 2 diabetes through the Associazione Medici Diabetologi‐annals initiative: a long‐term cost‐effectiveness analysis

Giorda, C. B., Nicolucci, A., Pellegrini, F., Kristiansen, C. K., Hunt, B., Valentine, W. J., Vespasiani, G.·2014·Diabetic Medicine

Abstract

Aims The Associazione Medici Diabetologi-annals initiative is a physician-led quality-of-care improvement scheme that has been shown to improve HbA1c concentration, blood pressure, lipid profiles and BMI in enrolled people with Type 2 diabetes. The present analysis investigated the long-term cost-effectiveness of enrolling people with Type 2 diabetes in the Associazione Medici Diabetologi-annals initiative compared with conventional management. Methods Long-term projections of clinical outcomes and direct costs (in 2010 Euros) were made using a published and validated model of Type 2 diabetes in people with Type 2 diabetes who were either enrolled in the Associazione Medici Diabetologi-annals initiative or who were receiving conventional management. Treatment effects were based on mean changes from baseline seen at 5 years after enrolment in the scheme. Costs and clinical outcomes were discounted at 3% per annum. Results The Associazione Medici Diabetologi-annals initiative was associated with improvements in mean discounted life expectancy and quality-adjusted life expectancy of 0.55 years (95% CI 0.54-0.57) years and 0.48 quality-adjusted life years (95% CI 0.46-0.49), respectively, compared with conventional management. Whilst treatment costs were higher in the Associazione Medici Diabetologi-annals arm, this was offset by savings as a result of the reduced incidence and treatment of diabetes-related complications. The Associazione Medici Diabetologi-annals initiative was…

Integrity signals

Registry

Crossref · 10.1111/dme.12366

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Italy, the Associazione Medici Diabetologi-annals initiative is a cost-saving method of improving clinical outcomes in type 2 diabetes mellitus patients because it improves HbA1c, blood pressure, lipid profiles, and BMI compared to conventional management methods.

    “In Italy, the long-term projections of the Associazione Medici Diabetologi-annals initiative (a physician-led quality-of-care improvement program for T2DM patients) indicate that this initiative is a cost-saving method of improving clinical outcomes in T2DM patients because it improves HbA1c, blood pressure, lipid profiles, and BMI in enrolled patients compared to conventional management methods [”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Giorda, C. B., Nicolucci, A., Pellegrini, F., Kristiansen, C. K., Hunt, B., Valentine, W. J., & Vespasiani, G.
Affiliations
  • ASL TO5 Chieri Turin Italy
  • Mario Negri Sud Foundation (IT)
  • Novo Nordisk (Denmark) (DK)
  • Ossian Health Economics and Communications Basel Switzerland
  • Madonna del Soccorso Hospital San Benedetto del Tronto Italy
Corresponding author
Kristiansen, C. K.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2013-12-24
Volume
31
Issue
5
Pages
615-623
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2015147331
Cited by
17
References
23
Citations by year
2023: 3 · 2022: 1 · 2020: 3 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 1 · 2014: 1
FWCI
3.90
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetic Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Novo Nordisk
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
type 2 diabetes, healthcare quality improvement, cost-effectiveness, quality-adjusted life years, life expectancy, diabetes complications, HbA1c, Italy
MeSH terms
Aged, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Female, Humans, Italy, Male, Middle Aged, Quality of Health Care, Time Factors, Incidence, Health Care Costs, Outcome Assessment, Health Care, Quality-Adjusted Life Years, Disease Management, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review